\-\ Texto\\:\\ \ \(0\)\
\-\ liver\\ edge\\ palpable\\ to\\ 4\\ cm\\ below\\ ribcage\\ on\\ exam\\.\ \(0\)\
\-\ although\\ the\\ patient\\ had\\ used\\ tamoxifen\\ in\\ the\\ past\\,\\ she\\ was\\ considered\\ to\\ be\\ chemotherapy\\ naive\\.\\ due\\ to\\ systemic\\ dissemination\\ of\\ disease\\ it\\ was\\ decided\\ to\\ attempt\\ chemotherapy\\ first\\ and\\ reserve\\ radiation\\ therapy\\ as\\ a\\ palliative\\ option\\.\ \(0\)\
\-\ multiple\\ liver\\ lesions\\ replacing\\ approximately\\ 80\\%\\ of\\ liver\\ volume\\.\\ multiple\\ lesions\\ of\\ brain\\ parenchyma\\ in\\ bilateral\\ parietooccipital\\ regions\\ with\\ diffuse\\ enhancement\\ of\\ overlying\\ skull\\ and\\ dura\\.\ \(0\)\
\-\ metastatic\\ ductal\\ carcinoma\\ \\(breast\\)\ \(0\)\
\-\ metastatic\\ disease\\ \\-\\ melanoma\ \(0\)\
\-\ metastatic\\ disease\\ \\-\\ ductal\\ breast\\ ca\ \(0\)\
\-\ 60\\ year\\ old\\ woman\\ with\\ pmh\\ of\\ t1bn0m0\\ breast\\ ca\\ and\\ melanoma\\,\\ both\\ 9\\ years\\ ago\\.\\ s\\/p\\ lumpectomy\\,\\ xrt\\,\\ tamoxifen\\,\\ local\\ excision\\.\\ presents\\ with\\ 3\\ months\\ of\\ early\\ satiety\\ and\\ nausea\\.\\ additional\\ complaint\\ of\\ blurred\\ vision\\ when\\ looking\\ to\\ her\\ left\\ while\\ driving\\ for\\ 1\\ week\\.\ \(0\)\
\-\ this\\ is\\ a\\ rather\\ unfortunate\\ case\\ of\\ a\\ woman\\ who\\ was\\ concurrently\\ diagnosed\\ with\\ stage\\ i\\ breast\\ cancer\\ and\\ melanoma\\ 8\\ years\\ ago\\.\\ neither\\ disease\\ demonstrated\\ pathologic\\ lymph\\ node\\ involvement\\ at\\ time\\ of\\ initial\\ diagnosis\\ \\/\\ treatment\\.\\ sadly\\ she\\ now\\ demonstrates\\ diffuse\\ metastasis\\ of\\ pathologically\\ proven\\ ductal\\ carcinoma\\ involving\\ approximately\\ 80\\%\\ of\\ her\\ liver\\,\\ her\\ parietooccipital\\ brain\\ parenchyma\\ and\\ overlying\\ skull\\ and\\ meninges\\,\\ as\\ well\\ as\\ the\\ body\\ of\\ her\\ l4\\ vertebrae\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parietooccipital\\:\\ 0\\.07732910898216226\ \(0\)\
\-\ tamoxifen\\:\\ 0\\.05805520918096735\ \(0\)\
\-\ melanoma\\:\\ 0\\.0573838306278025\ \(0\)\
\-\ breast\\:\\ 0\\.055308034102290383\ \(0\)\
\-\ ductal\\:\\ 0\\.053000351068216475\ \(0\)\
\-\ liver\\:\\ 0\\.05168809668127585\ \(0\)\
\-\ her\\:\\ 0\\.04507739751727957\ \(0\)\
\-\ ribcage\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ naive\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ t1bn0m0\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ sadly\\:\\ 0\\.035624435278098915\ \(0\)\
\-\ 80\\:\\ 0\\.0352607708628926\ \(0\)\
\-\ ca\\:\\ 0\\.0349055834825879\ \(0\)\
\-\ overlying\\:\\ 0\\.033918934505160786\ \(0\)\
\-\ parenchyma\\:\\ 0\\.03192428676660236\ \(0\)\
\-\ skull\\:\\ 0\\.03192428676660236\ \(0\)\
\-\ reserve\\:\\ 0\\.03160561627865087\ \(0\)\
\-\ concurrently\\:\\ 0\\.030805960327800187\ \(0\)\
\-\ unfortunate\\:\\ 0\\.030129860854873618\ \(0\)\
\-\ dissemination\\:\\ 0\\.02856549706566865\ \(0\)\
\-\ metastatic\\:\\ 0\\.028304071100211714\ \(0\)\
\-\ ago\\:\\ 0\\.02790113000699341\ \(0\)\
\-\ satiety\\:\\ 0\\.027089741641891398\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0268679454836918\ \(0\)\
\-\ driving\\:\\ 0\\.026787141328352138\ \(0\)\
\-\ replacing\\:\\ 0\\.026504077639152263\ \(0\)\
\-\ meninges\\:\\ 0\\.026238180175045096\ \(0\)\
\-\ xrt\\:\\ 0\\.025525377852686434\ \(0\)\
\-\ blurred\\:\\ 0\\.0251073507482815\ \(0\)\
\-\ neither\\:\\ 0\\.0251073507482815\ \(0\)\
\-\ pathologically\\:\\ 0\\.02491238687735679\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.024725721901835754\ \(0\)\
\-\ disease\\:\\ 0\\.024504167389749195\ \(0\)\
\-\ decided\\:\\ 0\\.02437465739449568\ \(0\)\
\-\ dura\\:\\ 0\\.02374702211536992\ \(0\)\
\-\ looking\\:\\ 0\\.02374702211536992\ \(0\)\
\-\ approximately\\:\\ 0\\.023191384443470024\ \(0\)\
\-\ palliative\\:\\ 0\\.02282719522509769\ \(0\)\
\-\ diffuse\\:\\ 0\\.022693047547151884\ \(0\)\
\-\ brain\\:\\ 0\\.022555715116690894\ \(0\)\
\-\ l4\\:\\ 0\\.02216806275558305\ \(0\)\
\-\ years\\:\\ 0\\.02201090471068844\ \(0\)\
\-\ vertebrae\\:\\ 0\\.0215951672186661\ \(0\)\
\-\ attempt\\:\\ 0\\.021506558853238385\ \(0\)\
\-\ proven\\:\\ 0\\.021334538181513464\ \(0\)\
\-\ carcinoma\\:\\ 0\\.021244979561542688\ \(0\)\
\-\ she\\:\\ 0\\.021041983696966422\ \(0\)\
\-\ edge\\:\\ 0\\.021009503215926966\ \(0\)\
\-\ option\\:\\ 0\\.02093187349180679\ \(0\)\
\-\ lesions\\:\\ 0\\.02006632023108726\ \(0\)\
\-\ pmh\\:\\ 0\\.018645483475871326\ \(0\)\
\-\ \\/\\:\\ 0\\.018510520060666263\ \(0\)\
\-\ systemic\\:\\ 0\\.017930397391465604\ \(0\)\
\-\ rather\\:\\ 0\\.017815474705526902\ \(0\)\
\-\ volume\\:\\ 0\\.01770348653883758\ \(0\)\
\-\ \\%\\:\\ 0\\.017485272222333398\ \(0\)\
\-\ complaint\\:\\ 0\\.01731571918206542\ \(0\)\
\-\ vision\\:\\ 0\\.01731571918206542\ \(0\)\
\-\ woman\\:\\ 0\\.017314938135867597\ \(0\)\
\-\ local\\:\\ 0\\.017215654805898\ \(0\)\
\-\ regions\\:\\ 0\\.017150191427754688\ \(0\)\
\-\ node\\:\\ 0\\.017150191427754688\ \(0\)\
\-\ as\\:\\ 0\\.017007598761764837\ \(0\)\
\-\ pathologic\\:\\ 0\\.016405020213739786\ \(0\)\
\-\ 60\\:\\ 0\\.01635053547690401\ \(0\)\
\-\ below\\:\\ 0\\.016270056798534726\ \(0\)\
\-\ \\-\\:\\ 0\\.016067793497441786\ \(0\)\
\-\ stage\\:\\ 0\\.01598699310933485\ \(0\)\
\-\ multiple\\:\\ 0\\.015787771960344463\ \(0\)\
\-\ s\\/p\\:\\ 0\\.01572109564522768\ \(0\)\
\-\ 9\\:\\ 0\\.015492608312405743\ \(0\)\
\-\ i\\:\\ 0\\.015492608312405743\ \(0\)\
\-\ excision\\:\\ 0\\.015382678625286373\ \(0\)\
\-\ considered\\:\\ 0\\.015129571969055467\ \(0\)\
\-\ lymph\\:\\ 0\\.015129571969055467\ \(0\)\
\-\ nausea\\:\\ 0\\.015088772001238301\ \(0\)\
\-\ additional\\:\\ 0\\.015028274974342093\ \(0\)\
\-\ used\\:\\ 0\\.014378000688368253\ \(0\)\
\-\ metastasis\\:\\ 0\\.014029593536403186\ \(0\)\
\-\ 8\\:\\ 0\\.014013673501093633\ \(0\)\
\-\ diagnosed\\:\\ 0\\.01378155770524125\ \(0\)\
\-\ involvement\\:\\ 0\\.013736573055385158\ \(0\)\
\-\ early\\:\\ 0\\.013706837586151042\ \(0\)\
\-\ palpable\\:\\ 0\\.013283425625437677\ \(0\)\
\-\ involving\\:\\ 0\\.013150909052646024\ \(0\)\
\-\ was\\:\\ 0\\.013003651608074826\ \(0\)\
\-\ now\\:\\ 0\\.012811910481147576\ \(0\)\
\-\ week\\:\\ 0\\.012728137799685211\ \(0\)\
\-\ although\\:\\ 0\\.012657584563932471\ \(0\)\
\-\ first\\:\\ 0\\.012576681731516895\ \(0\)\
\-\ initial\\:\\ 0\\.012419219926663632\ \(0\)\
\-\ cancer\\:\\ 0\\.012320900282301601\ \(0\)\
\-\ radiation\\:\\ 0\\.01229934758579972\ \(0\)\
\-\ body\\:\\ 0\\.012172209266180194\ \(0\)\
\-\ past\\:\\ 0\\.01190876961380015\ \(0\)\
\-\ while\\:\\ 0\\.011792321227422426\ \(0\)\
\-\ demonstrated\\:\\ 0\\.01099745606340775\ \(0\)\
\-\ when\\:\\ 0\\.010733908936912305\ \(0\)\
\-\ time\\:\\ 0\\.010585970294909266\ \(0\)\
\-\ 4\\:\\ 0\\.010442859233241427\ \(0\)\
\-\ months\\:\\ 0\\.010236584625833628\ \(0\)\
\-\ cm\\:\\ 0\\.010052439113232394\ \(0\)\
\-\ enhancement\\:\\ 0\\.010046003360188753\ \(0\)\
\-\ therapy\\:\\ 0\\.010020354369476372\ \(0\)\
\-\ due\\:\\ 0\\.010001215583126489\ \(0\)\
\-\ who\\:\\ 0\\.00977179126816536\ \(0\)\
\-\ both\\:\\ 0\\.009571052590728601\ \(0\)\
\-\ to\\:\\ 0\\.009365528693925138\ \(0\)\
\-\ bilateral\\:\\ 0\\.00909569179523879\ \(0\)\
\-\ 1\\:\\ 0\\.008918098105086434\ \(0\)\
\-\ 3\\:\\ 0\\.008776208450467279\ \(0\)\
\-\ diagnosis\\:\\ 0\\.008606225135001842\ \(0\)\
\-\ well\\:\\ 0\\.008478425232318645\ \(0\)\
\-\ it\\:\\ 0\\.00842477361637288\ \(0\)\
\-\ \\,\\:\\ 0\\.008311273941320226\ \(0\)\
\-\ exam\\:\\ 0\\.008233482192761132\ \(0\)\
\-\ case\\:\\ 0\\.008199580845909082\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008186935094970114\ \(0\)\
\-\ had\\:\\ 0\\.00808706061070486\ \(0\)\
\-\ presents\\:\\ 0\\.007656334629420727\ \(0\)\
\-\ treatment\\:\\ 0\\.007586039296495118\ \(0\)\
\-\ of\\:\\ 0\\.006131778989367812\ \(0\)\
\-\ be\\:\\ 0\\.005779634751508461\ \(0\)\
\-\ and\\:\\ 0\\.00552659228125232\ \(0\)\
\-\ a\\:\\ 0\\.005218418444981596\ \(0\)\
\-\ at\\:\\ 0\\.0050779085650510215\ \(0\)\
\-\ this\\:\\ 0\\.004215514093483039\ \(0\)\
\-\ year\\:\\ 0\\.004193444163477696\ \(0\)\
\-\ left\\:\\ 0\\.004193444163477696\ \(0\)\
\-\ old\\:\\ 0\\.0038374324423783093\ \(0\)\
\-\ patient\\:\\ 0\\.0037569821531420523\ \(0\)\
\-\ in\\:\\ 0\\.0036964669310548676\ \(0\)\
\-\ for\\:\\ 0\\.0031978427572048906\ \(0\)\
\-\ on\\:\\ 0\\.003174960580550123\ \(0\)\
\-\ \\(\\:\\ 0\\.0031682531852800897\ \(0\)\
\-\ \\)\\:\\ 0\\.003129551281198706\ \(0\)\
\-\ is\\:\\ 0\\.0024661876244944105\ \(0\)\
\-\ with\\:\\ 0\\.0020527048436822758\ \(0\)\
\-\ \\.\\:\\ 0\\.0018683966367024354\ \(0\)\
\-\ the\\:\\ 0\\.0018190695355740235\ \(0\)\
